IL1B and mastitis: Likewise, dose-dependent decreases in several inflammatory markers during mastitis, including MPO activity (Fig 1F), and TNF-α (Fig 1G) and IL-1β (Fig 1H), were detected after HEX treatment compared with S. aureus treatment.